CALL US AT 800-952-0521

Botox® Developer Regrets Missed Opportunity to Mint Money

Monday, March 12, 2012

Botox® developer Alan Scott, who sold the rights for the wrinkle-smoothing drug to a US company for just $4.5 million, says he regrets the move.

Botox® has become a front-line weapon in cosmetic medicine for erasing wrinkles — while therapeutic applications of the drug are being used to help a wide variety of disorders from swallowing problems to muscle spasms.

“If I knew (how big it would become), I would have never given it to the drug company Allergan in 1991,” Dr Alan Scott told the Times of India in an interview published on Monday.


Blog Categories

Related Posts

Botulinum Toxin Options

By Sydney Gatta, RN We’ve all heard of Botox, right?! While Botox has been around for a very long time, it has become wildly more